在摩根士丹利投资者会议上发表演讲后，CVS下跌4%

2025-09-09 02:46

CVS Health (NYSE:CVS) shares are down ~4% in Monday afternoon trading following a presentation by top executives at the Morgan Stanley Global Healthcare Conference.
The presentation didn't include any updated financial guidance or commentary on the upcoming release from the federal government on star ratings for Medicare Advantage plans. The ratings come out in the fall.
CEO David Joyner and CFO Brian Newman presented at the conference, Bloomberg reported.
One of the two execs, aware of the stock drop during the presentation, said later that CVS has a policy of not providing updated guidance between quarterly earnings releases.
Star ratings are important for companies offering Medicare Advantage plans as they indicate the quality and performance of each plan. The more stars, the more highly regarded the plan is, which can impact customer selection.
CVS offers MA plans through its Aetna subsidiary. The company has previously said that for 2025, 88% of its MA members were in plans rated 4-stars or higher.

More on CVS